Trials / Sponsors / Haibo Zhang
Haibo Zhang
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Tislelizumab Combined With Anlotinib and 2-cycles Irinotecan as Second Line Treatment of SCLC Small Cell Lung Cancer (SCLC) | N/A | 2021-09-30 |